The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Specificity of antibody response to 23-valent pneumococcal polysaccharide vaccine in patients with chronic pulmonary diseases
Author(s): 
Pages: 2002-2004
Year: Issue:  17
Journal: Jiangsu Medical Journal

Keyword:  肺炎链球菌多糖疫苗 慢性肺部疾病 血清型特异性IgG;
Abstract: 目的探讨慢性肺部疾病患者接种23价肺炎链球菌多糖疫苗(PPV)后血清中抗肺炎链球菌荚膜多糖(CPS)IgG抗体的特异性。方法以39例慢性肺部疾病患者为研究对象,分别用第二代和特异性更高的第三代ELISA测定疫苗接种前、后血清中的肺炎链球菌6B、19F和23F三种血清型的特异性IgG抗体浓度。结果用第三代ELISA测得的患者血清中血清型特异性IgG抗体水平比用第二代ELISA测得的抗体水平显著降低。无论是PPV接种前的自然感染,还是PPV接种后的主动免疫,慢性肺部疾病患者血中产生的抗CPS-IgG中都有大约一半的非特异性抗体。结论 PPV接种并不能提高慢性肺部疾病患者血中的特异性抗CPS-IgG的比例。
Related Articles
loading...